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Abstract: 
Adolescents are an important target for microbicide research, as they are disproportionately 
affected by sexually transmitted infections and currently are underrepresented in the microbicide 
research literature. Furthermore, adolescents are psychosocially and biologically different from 
adults, and findings from adult research cannot be assumed to apply universally to adolescents. 
Adolescents, to date have rarely been included in clinical trials and acceptability research for 
microbicides, in part because their participation requires attention to unique developmental 
issues, including parental consent and confidentiality. Despite these challenges, adolescents 
should be included in microbicide clinical research. If adolescents are ultimately expected to use 
microbicides, it is essential that we understand the developmental, contextual, and relationship 
variables that may influence use and acceptability. Accordingly, the goal of this paper was to 
examine the issues affecting the inclusion of adolescents in microbicide clinical research as well 
as review the existing adolescent-specific microbicide research, which highlights the various 
factors that may influence use and acceptability. It is hoped that this review can provide guidance 
for future work with this important, specialized population. 
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Article: 
Introduction 
Sexually Transmitted Infections and Microbicides 
Globally and in the United States, sexually active adolescents and young adults are at a high risk 
of acquiring sexually transmitted infections (STIs), including human immunodeficiency virus 
(HIV).1 and 2 For example, a recent US Centers for Disease Control and Prevention (2008) 
study reported that 1 in 4 adolescent women between the ages of 14 and 19 is infected with an 
STI. Given that women share a disproportionate burden of STIs compared to men, it is critical 
that women have methods they can initiate to protect themselves. The female condom provides a 
potential option, but it has not gained widespread acceptance.3 and 4 Although correct and 
consistent use of male condoms effectively reduces the risk of STIs,5 regular use of condoms is 
limited by women's need to negotiate condom use with their male partners,6 and 7 and even 
when women are able to negotiate condom use, they may choose not to out of a desire for 
intimacy, increased physical sensation, or to please their partner.8 and 9 Thus, microbicides may 
be useful in increasing women's ability to protect themselves.10 
Microbicides are creams, gels, films, or foams that can be inserted into the vagina or rectum to 
protect against STIs and, in some cases, pregnancy.11 Currently there are more than 10 
microbicide formulas in clinical trials, including 1 product in a phase III trial.12 Microbicide 
production delays have been attributed primarily to the complex physiology of the vaginal and 
rectal environments and the lack of research funding mechanisms.13 In addition to prevention 
properties, microbicides may affect sexual comfort and pleasure, as most formulas will have 
lubricating qualities.14, 15, 16 and 17 Microbicides, then, offer a unique compromise between 
the reduction of infection risk and potential influence on sexual performance and pleasure, 
thereby highlighting the importance of research. If safe, effective, and acceptable microbicides 
can be developed, then these woman-initiated methods have the potential to limit the 
transmission of STIs, including HIV. 
 
Microbicides have great promise for adolescents; however, the majority of microbicide research 
has been conducted with adults. Thus, the purpose of this paper is to explore the adolescent-
specific issues that influence the inclusion of adolescents in microbicide clinical research as well 
as review the extant adolescent microbicide research. It is hoped that this review can provide 
guidance for future work with this important, specialized population. 
 
Adolescence 
Adolescence is a phase of physical and psychosexual maturation as well as a transitional period 
into adulthood. There are distinct issues affecting adolescent sexual risk and protective 
behaviors, including parent relationships, limited sexual experience, lower usage of disease- and 
pregnancy-prevention methods, often spontaneous sexual opportunity, and lack of information 
regarding protective behaviors in school sexuality education programs.18, 19, 20 and 21 The key 
areas of adolescents' developmental changes include biology, cognition, and social behavior and 
functioning, which have implications for the use of vaginal microbicides by adolescent women. 
 
With regard to biological factors, adolescence is a time of hormonal changes, cervix maturation, 
and varying menstrual patterns.13 It is unknown whether the immature and developing 
gynecological tract of the adolescent woman would have an influence on safety or efficacy of 
microbicides. For instance, during the period after menarche, the columnar epithelium extends to 
the outer surface of the cervix, potentially increasing susceptibility to infection. Additionally, 
there may be aspects of adolescents' sexual behavior that influence microbicide efficacy or 
safety. Adolescent women, for example, may be less likely to be sufficiently aroused at the time 
of sexual intercourse and therefore have less vaginal lubrication. This lower level of lubrication 
may make a microbicide with lubricating qualities more acceptable and desirable,16 and 17 but it 
may also have an impact on safety and efficacy. It is possible with less natural fluid in the genital 
tract that the product would not spread sufficiently to provide protection. These key 
developmental factors highlight the need for adolescents to participate in, and benefit from, 
microbicide research.19 and 22 
 
Inclusion of Adolescents in Clinical Research 
It is necessary to include adolescents in reproductive health research, as they appear to have 
unique vulnerabilities to STIs. With increased cognitive skills, adolescents have a greater 
capacity to be involved in decision making about participation in research, including clinical 
trials. However, adolescents' involvement in decision making occurs within a social and legal 
context in which parental consent is required. Therefore, the prospect of including adolescents in 
clinical trials raises a variety of legal, ethical, and practical issues (eg, how, when, and where to 
obtain parental consent and how to ensure protection of minors, who are considered vulnerable 
persons). The necessity of parental involvement is complicated by issues related to informed 
consent, confidentiality, and promotion of adolescent autonomy.22, 23 and 24 The challenge in 
including adolescents in microbicide trials, therefore, is how to obtain parental and adolescent 
consent while protecting participant privacy and confidentiality.13 
 
Although adolescents are developing the necessary skills to be more involved in decisions 
related to research participation, the need to negotiate the social and legal context continues. An 
approach that has been suggested to include adolescents in microbicide clinical trials is to 
conduct adult-only phase I and II trials to determine safety.13 Once safety is confirmed, a 
combined phase I/II trial could be conducted with adolescents, with movement toward an 
integrated adult/adolescent phase III trial.13 Once adolescents are recruited, there will be other 
issues to be considered, including retention, access to health care, and maintaining 
confidentiality. These issues are important but do not preclude including adolescents in the 
research. Requiring parental consent for safety and efficacy studies should not detract from the 
study results, as adolescent women's anatomy and physiology are relatively similar to each other 
(although different from those of adults). Issues such as the waiving of parental consent will be 
most pertinent in acceptability studies, where there may be important differences (eg, sexual 
experience, parent-child communication) between adolescents who are willing and not willing to 
obtain parental consent. 
 
The requirement of parental consent in microbicide research may pose a barrier to inclusion for 
adolescents who do not wish to disclose sexual behaviors to their parents.13, 19, 22 and 24 The 
(inadvertent) exclusion of a subsample of sexually experienced adolescents, who choose not to 
get parental consent, means that their experiences and attitudes, which are particularly relevant, 
remain unknown. It may be necessary to wait until microbicides are approved to examine this 
group's assessment, as waiving parental consent for an approved product would be less difficult. 
It is notable, however, that there have been microbicide studies that have required parental 
consent and have included women as young as 14.25 and 26 These studies demonstrate that 
parental consent can be obtained from parents of younger adolescents and highlight the 
importance of not shying away from requiring parental consent, but recognizing and 
acknowledging the implications in terms of the potential for selection bias. 
 
A strategy to ease the parental consent process and enhance participant privacy is to allow 
obtaining consent over the phone.22 This strategy limits the degree to which parental consent is a 
barrier by allowing the participation of adolescents whose parents did not accompany them to the 
study site. Another strategy is to discuss with parents the need to keep confidential the 
information provided by their child. If a parent agrees, his or her daughter can be informed prior 
to beginning the study that confidentially is protected. This issue is especially relevant when 
exclusion criteria include such things as a positive pregnancy or HIV test. It is essential that 
confidentiality discussions with the parent and adolescent be extremely open and detailed before 
study initiation. Understanding the complex nature of adolescent-parent relationships and 
working to balance parental involvement and adolescent autonomy is necessary to ensure their 
privacy and navigate inclusion in studies.19 and 22 
 
An additional challenge to including adolescents in research is how to access their sexual 
partners, in terms of both the relational and the legal issues. Adolescents tend to have shorter-
term and less involved relationships,27 which can complicate the identification of partners and 
impede efforts to recruit them. In addition, a legal issue was identified in attempts to recruit 
adolescent women's partners.28 The Institutional Review Board expressed concerns regarding 
adolescent women identifying older partners and thereby inadvertently raising the issue of 
statutory rape.28 A continuing dialogue regarding how to address this issue will be important, as 
it is essential that adolescents (both women and men) have the opportunity to freely choose to 
participate in microbicide research to ensure that it is consistent with the research principles of 
respect, justice, and beneficence.18 and 29 Again, to meet these overarching research 
principles,29 adolescent women (and their partners) should have the chance to participate in 
microbicide research. The practical realities of the need to know about microbicide safety, 
efficacy, and acceptability require that we ask how to include adolescents, not whether to include 
them. 
 
Existing Adolescent Microbicide Research 
Microbicide Acceptability 
A significant amount of funding, including federal monies, is currently being devoted to 
microbicide production.30 Once microbicides are proven safe and effective, they need to be 
acceptable and usable.31 Dimensions of acceptability will likely differ based on the cultural and 
developmental characteristics of the population.32 Acceptability research, then, is particularly 
crucial for adolescents, as they remain a population that is disproportionately influenced by the 
burden of STI/HIV33 and could greatly benefit from a woman-initiated prevention method, 
particularly with the challenges that can arise around discussing condom use with a partner.34 
 
As microbicides are not currently commercially available, most of the adolescent/young adult 
acceptability work has assessed hypothetical product characteristics to predict use26 and 35 or 
used vaginal moisturizers or lubricants as proxy microbial products to assess behavioral 
correlates of use.16 and 22 As microbicides will be used within sexual partnerships, it is 
important to explore the ways in which microbicides will be negotiated within the sexual 
interaction. Therefore, an understanding of preferences for specific microbicide qualities, as well 
as how other people may influence adolescent women's decision to use microbicides, is essential. 
 
Product Characteristics 
Extant microbicide acceptability research with adolescent women has reported varied individual 
preferences regarding product characteristics. Adolescent women generally favored both 
pregnancy and disease prevention in a single product,26 and 35 however, this preference 
changed with reproductive health goals. Women who were trying to become pregnant, for 
instance, preferred a product with STI/HIV prevention properties only.16 and 20 Previous 
research indicated that potential side effects may influence microbicide acceptability and use, 
including yeast infections, vaginal itching, penile irritation, and allergic reactions.20, 26 and 36 
In addition, associations with the microbicide proxy to other products influenced use; for 
example, if a microbicide seemed to have similar properties to a yeast infection medication, it 
was a perceived barrier to use.17 Adolescent women indicated that microbicides should be 
promoted through youth-specific venues, such as magazines.36 There was also a reported desire 
for microbicides to be small enough to carry in a pocket, bra, or within a cell phone or palm pilot 
case.36 
 
Timing of microbicide application preferences varied. Some young women reported a preference 
for insertion up to 8 hours in advance of coitus.35 Other young women, however, did not 
appreciate the prescribed waiting period and preferred application right before intercourse, as sex 
was not always planned.16 and 20 Post-coital application was appealing to some women, as they 
could avoid having a conversation about use with their partner16 and in case they forgot to apply 
the product in the “heat of the moment.”36 In addition, there was a desire for lubricating 
products,16 and 17 but with minimal messiness17 and leakage.35 and 37 For some young 
women and their partners, the lubricating properties were thought to be beneficial in increasing 
sexual comfort and pleasure.16 and 17 Overall, adolescent women wanted microbicides to be 
affordable, discreet, effective, comfortable, flexible, and without side effects. 
 
Adolescents and Social Network Influence on Microbicide Acceptability and Use 
Existing research suggests that sexual partners, family, and health care providers will affect the 
acceptability and use of microbicides by adolescents. Issues associated with microbicide 
acceptability have focused on these important people as influential in decision making, 
encouraging use, communication, and information dissemination. 
 
Male partners and microbicide acceptability 
As microbicides will be used within a dyadic sexual interaction, adolescent women and men are 
both important targets for microbicide promotion. Little work has directly addressed young 
men's acceptability of microbicides. The few studies reported, similar to young women's 
evaluations, considerable variation in young men's evaluations of and concerns related to 
microbicides. The results indicated young men placed an emphasis on sexual enhancement, had 
concerns regarding microbicide safety, and wanted their partners to tell them about use.28 and 38 
 
Male partners' attitudes toward microbicides or to similar products (eg, vaginal moisturizers) 
have also been explored indirectly through young women's reports. Comparable to adults,39 
adolescent women's specific relationship dynamics, including perceptions of male partners' 
assessment, communication ability, and comfort with covert use, influenced use of microbicide 
surrogates.25 and 40 Positive male evaluations resulted in an increased likelihood of use of a 
microbicide surrogate, whereas negative evaluations decreased the likelihood of use.40 Similar 
to discussions regarding other contraceptive and disease prevention methods,4 adolescent 
women described a variety of expectations and experiences when talking to their partners about 
microbicide/moisturizer use. Some young women reported ease in discussing microbicide 
surrogate use with their partners, whereas other women struggled with initiation of these 
discussions. 17 and 40 Young women in more established relationships or those who had known 
their partner for an extended period of time tended to be more comfortable communicating about 
microbicide surrogate use in comparison to women who defined their relationships as more 
casual.40 In addition, there was a reported willingness by some adolescent women to have their 
partner be present for microbicide application or let the partner insert the product.41 
 
Consistent with adult findings,3, 42 and 43 some adolescents expressed an interest in the 
potential of surreptitious microbicide use,16 though the majority of women reported telling their 
partners about use of the microbicide surrogate.17 and 40 The women who reported a desire for 
covert use said that they were motivated by a lack of trust in their main partner and reported 
wanting to do what they could to protect themselves.40 This desire for covert self-protection 
may arise from the real and perceived challenges that these women encounter in trying to 
negotiate male condom use, making microbicides, a woman-initiated method of STI prevention, 
an attractive option. 
 
Parents and microbicide acceptability 
Parents are frequently relied upon for health care information and decision making. Mothers 
have been identified as the most often accessed and most positive source of sexual health 
information.36 They also have a significant impact on adolescent women's decision making.44 
Consistent with this notion, adolescents have reported that parents will influence microbicide 
acceptance.16 and 44 When an adolescent woman had a positive relationship with her mother, 
they were more likely to discuss the use of a microbicide surrogate.44 These findings suggest 
that mothers, as relatively frequent providers of sexual health information, may be an effective 
avenue for promotion of microbicide use by their adolescents.44 
 
Health care providers and microbicide acceptability 
Health care providers are in a unique position to confidentially inform adolescent women (and 
men) about, as well as encourage use of, microbicides. One study of general health care 
providers reported that the majority would be comfortable counseling individuals about 
microbicide use.45 It is noteworthy that this was an adult-specific study and that providers may 
have more hesitation about encouraging use for adolescent women. Some health care providers, 
for instance, reported a concern that adolescents will prefer to use microbicides (likely a less 
effective prevention method) and will stop using condoms.20 It has been demonstrated, however, 
that providing adolescents with multiple contraception and disease prevention method options 
(eg, hormonal methods) does not decrease condom use.46 Therefore, it will be essential to work 
with providers to counsel and teach adolescent women and men about all of the available 
STI/HIV prevention methods, including microbicides. Overall, health care providers would be 
able to educate adolescents about microbicides, answer questions related to safety and efficacy, 
and monitor potential side effects.36 
 
Microbicide Access and Marketing 
Access to microbicides will be an important gauge of acceptance for adolescents.36 Research 
suggests that young women preferred a range of access venues, for instance, some wanted 
microbicides to be available by prescription35 or distributed through clinics.16 Others preferred 
over-the-counter availability of microbicides, yet they stated they would be embarrassed if 
purchasing the product in the presence of others.35 and 36 Finally, some adolescent women 
believed that microbicides should be distributed through schools and sexuality education 
classes.36 Thus, a variety of distribution options, as well as attractive packaging,3 may be 
necessary to increase adolescent women's and their partners' access to and likelihood of 
purchasing microbicides. 
 
The likely influence of partners, family, and health care providers on adolescents' microbicide 
acceptance and ongoing use suggests that microbicide marketing and educational campaigns 
should be directed to influential adults as well as adolescents and their partners. In addition, it 
may be necessary to develop multiple targeted strategies. For instance, health care providers are 
in a position to introduce products to adolescents and inform them about potential side effects. 
However, parents and teachers should also be informed about microbicides, as they have vital 
roles in the lives of adolescents and may be in a better position than health care providers to 
address issues around sustained use of microbicides. Additionally, the incorporation of male 
partners into microbicide promotion efforts will be critical.3 The use of media, including 
magazines and television, would also allow for creative options for the dissemination of 
information.41 and 44 
 
The introduction and promotion of microbicides as a disease-prevention method focusing on 
HIV may be met with some resistance due to the well-documented stigma associated with 
HIV,47 and 48 especially for adolescents who may face challenges in communicating with 
partners about the use of contraceptives and disease prevention methods.25 and 40 It may be 
important, therefore, to approach microbicide promotion by noting that disease prevention is 
only 1 of several attractive characteristics of microbicide use, which may include contraception 
and lubrication. Recent work has suggested that including sexual pleasure messaging in STI/HIV 
prevention campaigns may increase condom use rates15 and 49 and will likely also be a useful 
strategy in microbicide promotion. In addition, the promotion of microbicides will need to 
include adolescents' broader environmental, structural, social, and cultural context. For example, 
HIV prevalence will likely have implications for microbicide marketing based on geography; 
highlighting potential for HIV protection may be more useful in higher prevalence areas, 
whereas highlighting other characteristics (eg, lubrication for sexual comfort and pleasure) may 
be more beneficial in other areas. 
 
Conclusions and Recommendations for Future Research 
Adolescents are an important target for microbicide research, as they are disproportionately 
affected by STI and currently are underrepresented in the microbicide research literature. 
Furthermore, adolescents are psychosocially and biologically different from adults, and findings 
from adult research cannot be assumed to apply universally to adolescents. Moreover, the period 
of adolescence is not internally homogeneous, as 14-year-olds, for instance, are in a distinct 
developmental period from that of their 18-year-old counterparts. Therefore, it is essential to 
ensure that adolescents across a broad range of ages be included in microbicide research. The 
inclusion of adolescents in clinical trials would allow safety and efficacy information to be 
combined with what is known about acceptability of hypothetical and surrogate microbicides to 
create targeted microbicide promotion campaigns. Although first generation microbicides will 
likely be less effective than condoms at STI/HIV prevention,50 even a lower efficacy 
microbicide could have a significant public health impact, particularly when combined with 
condom use.35 and 51 We strongly recommend, therefore, that adolescents be included in future 
clinical trials and acceptability research,52 and 53 which will allow for an examination of 
adolescent developmental issues related to safety, efficacy, and acceptability, as well as 
developing targeted educational and promotional materials. 
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